S&P 500 7,728 -0.11% Nasdaq 26,445 -0.52% Dow Jones 53,792 -0.54% FTSE 100 10,824 -0.59% DAX 26,453 +1.25% Nikkei 225 67,524 +1.85% Hang Seng 25,440 -1.84% WTI Crude 82.93 +6.08% Gold 4,481 +3.23% US 10-Year Treasury Yield 4.654 -0.34% S&P 500 7,728 -0.11% Nasdaq 26,445 -0.52% Dow Jones 53,792 -0.54% FTSE 100 10,824 -0.59% DAX 26,453 +1.25% Nikkei 225 67,524 +1.85% Hang Seng 25,440 -1.84% WTI Crude 82.93 +6.08% Gold 4,481 +3.23% US 10-Year Treasury Yield 4.654 -0.34%

LATEST

PENGASSAN pushes to open Africa’s fuel market to Dangote products●Ukraine halted Black Sea tanker strikes after Vance's July 31 call with Zelenskyy, FT reports●Burnham warned of Iran war impact on UK growth next year●Standard Chartered-led Anchorpoint launches Hong Kong dollar stablecoin●US inflation eases as food costs cool●Investors snap up AG Mortgage Bank’s N3.97bn commercial paper with 100% subscription●Nebius stock surged after beating revenue expectations on booming AI cloud demand●Ukraine and Russia trade heaviest overnight strikes in weeks as 40-day campaign passes $8bn in damage●PENGASSAN pushes to open Africa’s fuel market to Dangote products●Ukraine halted Black Sea tanker strikes after Vance's July 31 call with Zelenskyy, FT reports●Burnham warned of Iran war impact on UK growth next year●Standard Chartered-led Anchorpoint launches Hong Kong dollar stablecoin●US inflation eases as food costs cool●Investors snap up AG Mortgage Bank’s N3.97bn commercial paper with 100% subscription●Nebius stock surged after beating revenue expectations on booming AI cloud demand●Ukraine and Russia trade heaviest overnight strikes in weeks as 40-day campaign passes $8bn in damage●

Wealth

This week’s solar eclipse could make stocks go down. No, really. Here’s why.

MarketWatch.com - Top Stories · 1h ago

This week’s solar eclipse could make stocks go down. No, really. Here’s why.

The eclipse on Wednesday is unlikely to lead to the end of the bull market. But could have some impact on investors.

Read the full story at MarketWatch.com - Top Stories →

More Wealth

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

MarketWatch.com - Top Stories · 20m ago

Nebius adds to the excitement around neocloud stocks with upbeat earnings of its own

MarketWatch.com - Top Stories · 21m ago

The $30 trillion Treasury market is facing a painful reckoning. How rising yields could squeeze your portfolio.

MarketWatch.com - Top Stories · 29m ago

CoreWeave’s stock is rocketing after earnings lead to praise from bulls and bears alike

MarketWatch.com - Top Stories · 1h ago